African Journal of
Microbiology Research

  • Abbreviation: Afr. J. Microbiol. Res.
  • Language: English
  • ISSN: 1996-0808
  • DOI: 10.5897/AJMR
  • Start Year: 2007
  • Published Articles: 5123

Full Length Research Paper

Assessing the polymorphism of DHFR gene from Plasmodium falciparum in the south of Côte d’Ivoire

Dagnogo Oléfongo
  • Dagnogo Oléfongo
  • UFR Biosciences, Felix Houphouët-Boigny University, BP V 34 Abidjan 01, Côte d'Ivoire.
  • Google Scholar
Ako Aristide Berenger
  • Ako Aristide Berenger
  • Institute Pasteur of Côte d'Ivoire, 01 BP 490 Abidjan 01, Côte d'Ivoire.
  • Google Scholar
Bla Kouakou Brice
  • Bla Kouakou Brice
  • UFR Biosciences, Felix Houphouët-Boigny University, BP V 34 Abidjan 01, Côte d'Ivoire.
  • Google Scholar
Dago Dougba Noel
  • Dago Dougba Noel
  • UFR Sciences Biologiques, Péléforo Gon Coulibaly University, BP1328 Korhogo, CoÌ‚te d’Ivoire.
  • Google Scholar
Coulibaly N'golo David
  • Coulibaly N'golo David
  • Institute Pasteur of Côte d'Ivoire, 01 BP 490 Abidjan 01, Côte d'Ivoire.
  • Google Scholar
Coulibaly Baba
  • Coulibaly Baba
  • Institute Pasteur of Côte d'Ivoire, 01 BP 490 Abidjan 01, Côte d'Ivoire.
  • Google Scholar
Touré Offianan André
  • Touré Offianan André
  • Institute Pasteur of Côte d'Ivoire, 01 BP 490 Abidjan 01, Côte d'Ivoire.
  • Google Scholar
Djaman Allico Joseph
  • Djaman Allico Joseph
  • UFR Biosciences, Felix Houphouët-Boigny University, BP V 34 Abidjan 01, Côte d'Ivoire.
  • Google Scholar


  •  Received: 24 February 2020
  •  Accepted: 31 March 2020
  •  Published: 31 May 2020

References

Adja AM, N'goran EK, Koudou BG, Dia I, Kengne P, Fontenille D, Chandre F (2011). Contribution of Anopheles funestus, An. gambiae and An. nili (Diptera: Culicidae) to the perennial malaria transmission in the southern and western forest areas of Côte d'Ivoire. Annals of Tropical Medicine and Parasitology 105:13-24.
Crossref

 

Adnan Y, Aamer AK, Muhammad FN, Huma F, Gillian M, Amed O, Matthew A, Nadia Z, Takala‑Harrison S (2018). Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan. Malaria Journal 17:471.
Crossref

 
 

Ako AAB, André TO, Marnie J, Louis KP, Simon-Pierre AN, Carol HS (2012). Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005. Infection and Drug Resistance 5:113-120.
Crossref

 
 

Ako AB, Toure OA, Johansson M, Traore R, Gbessi AE, Coulibaly MY, Nguetta SA, Koné PL, Hopkin SC (2014). Sulfadoxine-Pyrimethamine Resistant Haplotypes in Asymptomatically and Symptomatically Malaria Infected Individuals in Côte d'Ivoire. Malaria Chemotherapy Control and Elimination 3:1-10.

 
 

Core Team R (2013). A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0.

 
 

Daouda N, Baba D, Yaye DN, Daria VT, Rachel D, Amy KB, Aminata M, Clarissa V, Amanda L, Souleymane M, Omar N, Dyann FW, Sarah V (2013). Polymorphism in dhfr/dhps genes, parasite density and ex vivo response to pyrimethamine in Plasmodium falciparum malaria parasites in Thies, Senegal. International Journal for Parasitology: Drugs and Drug Resistance 3:135-142.
Crossref

 
 

Desai M, Gutman J, Taylor SM, Wiegand RE, Khairallah C, Kayentao K, Ouma P, Coulibaly SO, Kalilani L, Mace KE, Arinaitwe E, Mathanga DP, Doumbo O, Otieno K, Edgar D, Chaluluka E, Kamuliwo M, Ades V, Skarbinski J, Shi YP, Magnussen P, Meshnick S, Ter Kuile FO (2016). Impact of sulfadoxine-pyrimethamine resistance on effectiveness of intermittent preventive therapy for malaria in pregnancy at clearing infections and preventing low birth weight. Clinical Infectious Diseases 62:323-33.
Crossref

 
 

Djaman J, Ahibo H, Yapi HF, Bla KB, Ouattara L, Yavo W, N'guessan JD, Yapo A, Mazabraud A (2010). Molecular Monitoring of Plasmodium falciparaum Malaria isolates in Côte d'Ivoire: Genetic Markers (dhfr-ts, dhps, pfcrt, pfmdr-1) for antimalarial-drugs resistance. European Journal of Scientific Research 40:461-470.

 
 

Djaman AJ, Basco L, Mazabraud A (2002). Mise en place d'un système de surveillance de la chimiorésistance de Plasmodium falciparum à Yopougon (Abidjan) : étude in vivo de la sensibilité à la chloroquine et évaluation de la résistance à la pyriméthamine après analyse de la mutation ponctuelle du gène de la dihydrofolate reductase (dhfr). Cahiers Santé 12:363-367.

 
 

Ghyslain MN, Sunny O, Rosalynn O, Julian JG, Katja CG, Katharina P, Benedikt G, Florian K, Bertrand L, Jürgen FJ, Saadou I, Cally R, Peter GK, Martin PG (2011). High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine pyriméthamine treatment failures in vivo in Gabonese children. Malaria Journal 10:123.
Crossref

 
 

Gokpeya MB, Sackou KJ, Hounsa A, Oga S, Kouadio KL, Houénou Y (2013). Paludisme à Abidjan: Connaissances, attitudes, pratiques des meres d'enfants De 0 A 5 Ans. Caher de Santé Publique 12(1):53-60

 
 

Gosling RD, Gesase S, Mosha JF, Carneiro I, Hashim R, Lemnge M, Mosha FW, Greenwood B, Chandramohan D (2009). Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial. Lancet 374:1521-1532.
Crossref

 
 

Granado S, Manderson L, Obrist B, Tanner M (2011). Appropriating "Malaria": local responses to malaria treatment and prevention in Abidjan, Côte d'Ivoire. Medical Anthropology 30:102-121.
Crossref

 
 

Granado S, Obrist B, Manderson L, Tanner M (2009). The moment of sale: Treating malaria in Abidjan, Côte d'Ivoire'. Anthropology and Medicine 16:319-331.
Crossref

 
 

Gregson A, Plowe CV (2005). Mechanisms of resistance of malaria parasites to antifolates. Pharmacological Reviews 57:117-145.
Crossref

 
 

Henry MC, Eggelte A, Watson P, van Leeuwen D, Bakker DA, Kluin J (1996). Response of childhood malaria to Chloroquine and Fansidar in an area of intermediate Chloroquine résistance in Côte d'lvoire. Tropical Medicine and International Health 1:610-615.
Crossref

 
 

Henry MC, Niangué J, Koné M (2002). Quel médicament pour traiter le paludisme simple quand la chloroquine devient inefficace dans l'Ouest de la Côte d'Ivoire ? Médecine Tropicale 62:55-57.

 
 

Ingrid BM, John EH (2010). Antimalarial drugs: modes of action and mechanisms of parasite resistance. Future Microbiology 5(12):1857-1873.
Crossref

 
 

Kasturi H, Souvik B, Innocent S (2018). Drug resistance in Plasmodium. Nature Reviews Microbiology 16(3): 156-170.
Crossref

 
 

Kizito J, Kayendeke M, Nabirye C, Staedke SG, Clare IR, Chandler (2012). Improving access to health care for malaria in Africa: a review of literature on what attracts patients. Malaria Journal 11:1-14.
Crossref

 
 

Kouadio AS, Cissé G, Brigit O, Kaspar W, Zingsstag J (2006). Fardeau économique du paludisme sur les ménages démunis des quartiers défavorisés d'Abidjan, Côte d'Ivoire. VertigO - la revue électronique en sciences de l'environnement Hors-série 3. 
Crossref

 
 

Mathieu N, Rachida T, Leonardo KB, Prisca NC, David AM, Francine N (2007). Therapeutic efficacy of sulfadoxine-pyrimethamine and the prevalence of molecular markers of resistance in under 5-yearolds in Brazzaville, Congo. Tropical Medicine and International Health 12(10):1164-1171.
Crossref

 
 

Miguel RH, Coura JR, Samudio F, Suárez-mutis MC (2013). Evaluation of three different DNA extraction methods from blood samples collected in dried filter paper in Plasmodium subpatent infections from the Amazon region in Brazil. Revista do Instituto de Medicina Tropical de São Paulo 55(3):205-208.
Crossref

 
 

Min H (2012). Mapping the supply chain of anti-malarial drugs in Sub-Saharan African countries. International Journal of Logistics Systems and Management 11:1-23.
Crossref

 
 

MSHP (2013). Directives nationales de prise en charge du paludisme en Côte d'Ivoire. Abidjan, Côte d'Ivoire , Ministère de la Santé et de l'Hygiène Publique. 37p.

 
 

Nankabirwa J, Cundill B, Clarke S, Kabatereine N, Rosenthal PJ, Dorsey G, Brooker S, Staedke SG (2010). Efficacy, safety, and tolerability of three regimens for prevention of malaria: a randomized, placebo-controlled trial in Ugandan schoolchildren. PLoS ONE 5:e13438.
Crossref

 
 

Newton PN, Green MD, Fernandez FM (2010). Impact of poor-quality medicines in the 'developing' world. Trends in Pharmacological Sciences 31:99-101.
Crossref

 
 

Orostegui L, Balu L, Chevret L, Habes D, Pussard E (2011). Community Management of Anti-malarials in Africa and Iatrogenic Risk. Journal of Tropical Pediatrics 57:225-226.
Crossref

 
 

Ouattara L, Bla KB, Assi SB, Yavo W, Djaman AJ (2010). pfcrt and dhfr-ts Sequences for Monitoring Drug Resistance in Adzopé Area of Côte d'Ivoire After the Withdrawal of Chloroquine and Pyrimethamine. Tropical Journal of Pharmaceutical Research, December 9(6):568.
Crossref

 
 

Picot S, Olliaro P, de Monbrison F, Bienvenu AL, Price RN, Ringwald P (2009). A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Malaria Journal 8:89.
Crossref

 
 

Ratcliff A, Siswantoro H, Kenangalem E, Wuwung M, Brockman A, Edstein MD, Laihad F, Ebsworth EP, Anstey NM, Tjitra E, Price RN (2007). Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyriméthamine in southern Papua, Indonesia. Transactions of the Royal Society of Tropical Medicine and Hygiene 101:351-359.
Crossref

 
 

Ravi KU (2016). Emergence of drug resistance in Plasmodium falciparum: Reasons of its dispersal and transmission in different climatic regions of the world: a review. Clinical Microbiology and Infectious Diseases 1(2):45-55.
Crossref

 
 

Sankar S, Shannon KM, Luke MS, Karen MH, John WB, Venkatachalam U (2010). Antifolate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations. Malaria Journal 9:247.
Crossref

 
 

Shannon T-H, Miriam KL (2015). Antimalarial drug resistance in Africa: key lessons for the future. Annals of the New York Academy of Sciences 1342:62-67.
Crossref

 
 

Shunmay Y, Harriet LS, Lawford, Tabernero P, Nguon C, van Wyk A, Malik N, DeSousa M, Rada O, Boravann M, Dwivedi P, Hostetler DM, Swamidoss I, Green MD, Fernandez FM, Kaur H (2015). Quality of Antimalarials at the Epicenter of Antimalarial Drug Resistance: Results from an Overt and Mystery Client Survey in Cambodia. The American Journal of Tropical Medicine and Hygiene 92(Suppl 6):39-50.
Crossref

 
 

Somé AF, Sorgho H, Zongo I, Bazié T, Nikiéma F, Sawadogo A, Zongo M, Compaoré YD, Ouédraogo JB (2016). Polymorphisms in K13, pfcrt, pfmdr1, pfdhfr, and pfdhps in parasites isolated from symptomatic malaria patients in Burkina Faso. Parasite 23:60.
Crossref

 
 

Tinto H, Ouédraogo JB, Zongo I, Van Overmeir C, Van Marck E, Guiguemdé TR, D'Alessandro U (2007). Sulfadoxine-pyrimethamine efficacy and selection of Plasmodium falciparum DHFR mutations in Burkina Faso before its introduction as intermittent preventive treatment for pregnant women. American Journal for Tropical and Medicine Hygiene 76:608-613.
Crossref

 
 

Vladimir C, Murillo C, Echeverry DF, Benavides J, Pearce RJ, Roper C, Guerra AP, Osorio L (2010). Origin and Dissemination across the Colombian Andes Mountain Range of Sulfadoxine-Pyrimethamine Resistance in Plasmodium falciparum. Antimicrobial Agents and Chemotherapy 54(8):3121-3125
Crossref

 
 

WHO (2018). World Malaria report 2018. Geneva: World Health Organization; 2018. ISBN 978-92-4-156565-3

 
 

WHO (2016). WHO Policy recommendation on Intermittent Preventive Treatment during infancy with sulphadoxine-pyrimethamine (SP-IPTi) for Plasmodium falciparum malaria control in Africa.  

 
 

Yaro A (2009). Mechanisms of sulfadoxine pyrimethamine resistance and health implication in Plasmodium falciparum malaria: A mini review. Annals of Tropical Medicine and Public Health 2(1):20.